Berlin, Germany
Tarabios, a med-tech startup founded in 2020, is making strides in the Health Care industry by developing an innovative point-of-care (POC) self-diagnostic device. This Germany-based company is focused on creating a mobile device designed to monitor blood clotting times, specifically PT/INR, for patients undergoing Warfarin Therapy.
The company’s proprietary technology features a patented mechanical measurement system capable of assessing blood viscosity through a cartridge incorporating a microfluidic channel. This advancement positions Tarabios to extend its platform for additional low-cost, user-friendly diagnostic tests, opening doors to a broader range of disease detections.
In a promising move, Tarabios secured a $3.50M Seed Round investment on 02 July 2021 from Inventram, illustrating strong investor confidence in its vision and potential market impact. As Tarabios gears up to introduce its device to the market soon, it stands at a pivotal point for further development and expansion.
